Dundee researchers bring pioneering Parkinson’s trial to local patients
Dundee Culture9 Oct · 01:24← All topics · now
Development ↘
Development ↘
Development ↘
Development ↘
Right now
A phase 3 Parkinson’s drug trial has met its main goal.
4 reports · 9 Oct
Summary · from headlines2 points
- Solengepras met the primary endpoint in the Phase 3 ARISE trial of Parkinson disease.
- Dundee researchers brought a pioneering Parkinson’s trial to local patients.
Latest developments4 to read first
‘Absolutely staggering’: Results from experimental drug trial to prevent Parkinson’s disease
SMH.com.au9 Oct · 01:24Parkinson’s Pill Met Goals in Late-Stage Trial, Cerevance Says
Bloomberg.com9 Oct · 01:24Solengepras Meets Primary Endpoint in Phase 3 ARISE Trial of Parkinson Disease
NeurologyLive9 Oct · 01:24Timeline 4 reports
9 Oct 20264 reportsToday
01:004 reports
← All topics · nowOne topic